﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropharmacology</JournalTitle>
      <Issn>2345-4202</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Emerging cancer in individuals with cardiovascular disease: Exploring the intersection of reverse cardio-oncology and nephropharmacology</ArticleTitle>
    <FirstPage>e11648</FirstPage>
    <LastPage>e11648</LastPage>
    <ELocationID EIdType="doi">10.34172/npj.2023.11648</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Zandifar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0008-5316-8241</Identifier>
      </Author>
      <Author>
        <FirstName>Sadaf</FirstName>
        <LastName>Farnam Nia</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0004-4112-3063</Identifier>
      </Author>
      <Author>
        <FirstName>Rastina</FirstName>
        <LastName>Mehrani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5182-4294</Identifier>
      </Author>
      <Author>
        <FirstName>Bina</FirstName>
        <LastName>Bakhshaei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4518-7166</Identifier>
      </Author>
      <Author>
        <FirstName>Samin</FirstName>
        <LastName>Karamian</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0004-7650-2610</Identifier>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Bagheri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0006-5810-8163</Identifier>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Ghorbani</LastName>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Bakhshaei</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1517-0574</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>LETTER</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/npj.2023.11648</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>10</Month>
        <Day>02</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>11</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cardiovascular disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cardio‐oncology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Reverse cardio‐oncology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cardiovascular toxicity</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>